RE: CNSL one of the shares of 202413 Dec 2023 15:02
£4.4m was 30/9/23 - company confirmed that results would be in line with previous forecast -£3.8m at end of march
£4,9m revenue - inflated due to orders that could not be fulfilled last tax year and still company states
Adjusted EBITDA1 £0.0m (H1 2022: restated loss £0.4m).
· Loss before tax £0.7m (H1 2022: restated loss £0.8m).
revenue or capacity is not profit and does not guarantee it
also from rns
"H2 is expected to remain strong, although in the absence of any further backlog to fulfill, is expected to be slightly lower than H1 FY24 with the full year's revenue expected to be in line with market expectations."
in other words another loss making year and cash burn
"There is no further progress to report in our dispute with the Department of Health and Social Care ('DHSC'). "
so no mention of being more confident -
"The Board remains confident that the Company has a compelling case." - of course they have to say that to challenge gov..but in reality it is a nothing statement - thin smear of jam with nothing substantial to back it up
coming from the company who signed a non contract and didnt even realise it had lapsed
market agrees - just jam tomorrow and only a smear at that